Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis
Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis have?
Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis has 37 citations in the OpenAlex counts ScholarIQ stores.
When was Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis published?
Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis has 2016 year in the ScholarIQ index.
What is the open-access status of Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis?
Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis has gold oa status in the ScholarIQ index.
What is the DOI of Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis?
The DOI for Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis is on the source record.
What is the PMID of Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis?
The PMID for Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis is on the source record.
What is the OpenAlex record for Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis?
The OpenAlex for Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis is on the source record.